Skip to main content

Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer.

Davidson, M., Chau, I., Cunningham, D., Khabra, K., Iveson, T., Hickish, T. F., Seymour, M. and Starling, N., 2017. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World Journal of Gastrointestinal Oncology, 9 (8), 333 - 340.

Full text available as:

WJGO-9-333.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.


DOI: 10.4251/wjgo.v9.i8.333


AIM: To investigate the impact of histology on outcome in advanced oesophageal cancer treated with first-line fluoropyrimidine-based chemotherapy. METHODS: Individual patient data were pooled from three randomised phase III trials of fluoropyrimidine-based chemotherapy ± platinum/anthracycline in patients with advanced, untreated gastroesophageal adenocarcinoma or squamous cell carcinoma (SCC) randomised between 1994 and 2005. The primary endpoint was overall survival of oesophageal cancer patients according to histology. Secondary endpoints were response rates and a toxicity composite endpoint. RESULTS: Of the total 1836 randomised patients, 973 patients (53%) were eligible (707 patients with gastric cancer were excluded), 841 (86%) had adenocarcinoma and 132 (14%) had SCC. There was no significant difference in survival between patients with adenocarcinoma and SCC, with median overall survivals of 9.5 mo vs 7.6 mo (HR = 0.85, 95%CI: 0.70-1.03, P = 0.09) and one-year survivals of 38.8% vs 28.2% respectively. The overall response rate to chemotherapy was 44% for adenocarcinoma vs 33% for SCC (P = 0.01). There was no difference in the frequency of the toxicity composite endpoint between the two groups. CONCLUSION: There was no significant difference in survival between adenocarcinoma and SCC in patients with advanced oesophageal cancer treated with fluoropyrimidine-based chemotherapy despite a trend for worse survival and less chemo-sensitivity in SCC. Tolerance to treatment was similar in both groups. This analysis highlights the unmet need for SCC-specific studies in advanced oesophageal cancer and will aid in the design of future trials of targeted agents.

Item Type:Article
Uncontrolled Keywords:Adenocarcinoma ; Chemotherapy ; Oesophageal cancer ; Pooled analysis ; Squamous
Group:Faculty of Health & Social Sciences
ID Code:29843
Deposited By: Symplectic RT2
Deposited On:09 Oct 2017 11:39
Last Modified:14 Mar 2022 14:07


Downloads per month over past year

More statistics for this item...
Repository Staff Only -